New in Mycoses: A pooled Phase 2/3 analysis shows rezafungin was non-inferior to caspofungin for invasive candidiasis and candidaemia, with earlier mycological eradication and a comparable safety profile. Read more: doi.org/10.1111/myc.... #Mycoses #IDTwitter #MedMycology #Antifungals

Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials

Background The efficacy and safety of rezafungin in invasive candidiasis (IC) and candidaemia was demonstrated in the Phase 2 STRIVE and Phase 3 ReSTORE trials, and an additional cohort of patients ...

doi.org

📢 Jetzt zur MYK 2026 anmelden! Die 60. Wissenschaftliche Jahrestagung der Deutschsprachigen Mykologischen Gesellschaft findet vom 17.–19.09.2026 an der Medizinischen Universität Graz statt. 👉 dmykg-kongress.de/registrierung #MYK2026 #DMykG #Mykologie

Innovation only matters if patients can benefit from it. Domain 2 of the WHO Blueprint focuses on research, regulation and equitable access to antifungal medicines and diagnostics. www.who.int/publications... #Innovation #AMR

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

who.int

Better data saves lives. Domain 3 of the WHO Blueprint strengthens laboratory capacity, surveillance and outbreak preparedness to improve detection of fungal diseases and antifungal resistance. www.who.int/publications... #Surveillance #AMR

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

who.int

⏰ One week left! If you work in #MedicalMycology, please share your career & workplace experiences in the WIM × Womyc survey. Your voice will help shape a stronger community. ⏱️ ~11 min | 🔒 Anonymous | 📅 Closes 31 July www.clinicalsurveys.net/uc/wim-womyc...

📢 Kostenloses Webinar am 14. Juli | 17:00–18:15 Uhr Harnwegsinfekte: Welche Rolle spielt das Mikrobiom? Mit PD Dr. Lena Biehl. Aktuelle Erkenntnisse und neue Therapieansätze bei rezidivierenden Harnwegsinfektionen. Anmeldung: us06web.zoom.us/webinar/regi...

Welcome! You are invited to join a webinar: Harnwegsinfekte: Welche Rolle spielt das Mikrobiom? . After registering, you will receive a confirmation email about joining the webinar.

Harnwegsinfektionen sind eine der häufigsten bakteriellen Infektionen sowohl im stationären wie ambulanten Bereich. Insbesondere bei wiederkehrenden Harnwegsinfektionen zeigt die aktuelle Forschung ei...

us06web.zoom.us

⏳ Only 2 days left for the #ISHAMAsia2026 Early Bird rate! I'll be in Kuala Lumpur and hope to see many of you there. Use code FA10IA26 for an extra 10% off your registration. Register: isham.asia

Stronger health systems start with better fungal disease recognition, infection prevention, antifungal stewardship and equitable access to diagnostics and medicines. Explore Domain 1 of the WHO Blueprint: www.who.int/publications... #AMR

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengt...

who.int

🗓️ 06.10.2026 | Berlin Wie schützen wir Wissenschaft und Demokratie vor Desinformation und Angriffen auf die Wissenschaftsfreiheit? Diskutieren Sie mit beim Symposium „Wissenschaft pro Demokratie“. Anmeldung bis 22.09.: wpd-symposium.de #Wissenschaft #Demokratie #Science

Wir freuen uns über den Beitrag von KölnTourismus zu unserem Freiwilligenregister v-reg! 🙌 Jetzt informieren: location.koelntourismus.de/veranstaltun... Mitmachen: v-reg.eu #KlinischeForschung #Studienteilnahme

Forschungsprojekt VACCELERATE des CECAD abgeschlossen | locations.koeln

Ziel des Projekts war es, eine europaweite Forschungsinfrastruktur für klinische Impfstoffstudien aufzubauen. Hier mehr erfahren.

location.koelntourismus.de

A major step forward in tackling fungal diseases and antifungal resistance. The new WHO Implementation Blueprint translates the Fungal Priority Pathogens List into practical action across health systems, laboratories, innovation and One Health. www.who.int/publications... #AMR #FungalDiseases

Blueprint for strengthening responses to fungal disease and antifungal resistance

The Blueprint for strengthening responses to fungal disease and antifungal resistance Implementation guidance, provides a structured, operational framework to support countries and partners in strengthening coordinated responses to fungal disease and antifungal resistance (AFR).

who.int

🌍 Help shape the future of #OneHealth & #PlanetaryHealth education! If you're a health professional, educator or student, please take this 10-minute global survey coordinated by the WVA and partners. 🔗 redcap.uasz.sn/surveys/?s=J... Please share! #GlobalHealth

Registration is now open for the NIAID workshop Improving Clinical Outcomes for #Mucormycosis and Other Rare #Mold Infections (Aug 13–14, hybrid). Join experts to shape future clinical research and trial infrastructure. Register: cvent.me/2189Gn

📢 Work in medical mycology? Share your career and workplace experiences in the joint WIM × Womyc survey. Open to all career stages, backgrounds & genders. Anonymous, ~11 min. Closes July 31. Your voice matters! 🔗 www.clinicalsurveys.net/uc/wim-womyc...

Positive topline results from the Phase 3 #OASIS trial evaluating oral #olorofim for invasive #aspergillosis. The study met its primary endpoint. We are pleased to have contributed to patient enrollment in Cologne. #ClinicalTrials #FungalInfections f2g.com/press-releas...

F2G and Shionogi Announce Positive Topline Results from Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients with Invasive Aspergillosis | F2G.

The study achieved the primary endpoint of non-inferiority, with a rate of all-cause mortality (ACM) at Day 42 for olorofim of 23.8% and for AmBisome® follo ...

f2g.com

KIT 2026 in Köln: Die ersten beiden Kongresstage liegen hinter uns – mit spannenden Vorträgen, neuen Impulsen und vielen wertvollen Begegnungen. Danke für den bisherigen Austausch – wir freuen uns auf morgen! 📸 #KIT2026 #Infektiologie #Köln

The @ishamycology.bsky.social Pioneers in Mycology interview series celebrates the scientists who shaped modern medical mycology. Hear their stories, insights, and lessons for future generations. More interviews are coming in the months ahead. www.isham.org/about-isham/...

I’m excited to be attending ISHAM Asia 2026 in Kuala Lumpur, Malaysia, where experts in medical mycology will share the latest advances in fungal disease diagnosis and management. 🎟️ Get 10% off registration with referral code: FA10IA26 isham.asia @ishamycology.bsky.social

@salmantongarcia.bsky.social represented our team at the #EHA2026 Congress in Stockholm, connecting with leading experts and exploring the latest developments in hematology. Great conversations, valuable insights, and new perspectives to bring back to our work. #Hematology #Healthcare

New in the @ishamycology.bsky.social Pioneers in Mycology series: Prof. Flavio Queiroz-Telles reflects on his career, endemic mycoses, fungal disease recognition, and the future of medical mycology. Watch now and explore the full series: www.isham.org/about-isham/... #MedMycology #FungalDiseases

Neue Entwicklungen im Management von Candida-Infektionen: zunehmende Resistenzen, neue EUCAST-Breakpoints und innovative Therapien wie Rezafungin (1×/Woche), Ibrexafungerp & Fosmanogepix. Wichtiges Update aus der #Mykologie. www.thieme-connect.de/products/ejo... #Candida @rosannesprute.bsky.social

⚽ Zum Start der Fußball-WM 2026 gilt auch abseits des Spielfelds: Ein starkes Team braucht eine starke Abwehr. Impfungen schützen Einzelne, stärken Gemeinschaften und schaffen Sicherheit für die Zukunft. 💙 #WM2026 #Impfen #Prävention #Gesundheit #Teamgeist

🧪 Gestalten Sie die Medizin von morgen mit! Werden Sie Teil unseres Freiwilligen-Registers und unterstützen Sie klinische Forschung. An welche Untersuchungen Sie teilnehmen möchten, entscheiden Sie jederzeit selbst. Jetzt informieren und registrieren: v-reg.eu #KlinischeStudien #Forschung

Homepage - de - v-reg.eu

Unsere Investition in die Zukunft sind klinische Studien! Mit unseren Studien erforschen wir Krankheiten und hoffen, somit viele Menschenleben zu retten. Unsere Untersuchungen sind vielfältig und reic...

v-reg.eu

Countdown zum KIT 2026 in Köln! Wir freuen uns auf ein spannendes Programm und zahlreiche Beiträge spannende aus unserem Team. Bis bald im Gürzenich! kit-kongresse.de #KIT2026 #Infektiologie #Tropenmedizin #AMR #GlobalHealth

17. Kongress für Infektionskrankheiten und Tropenmedizin

Treffen Sie führende Experten auf dem KIT2026 in Köln, einem wegweisenden Kongress für Infektiologie und Tropenmedizin. Entdecken Sie die neuesten Durchbrüche und Forschungsergebnisse in den Bereichen...

kit-kongresse.de

🔬🩺 Aus dem Labor ans Krankenbett Wie aus Grundlagenforschung medizinischer Fortschritt wird erklären Professor @olivercornely.bsky.social und Professor @muellerrom.bsky.social im aktuellen #Unimagazin. Zum Artikel ▶️ uni.koeln/LHSE3 #uniköln #unicologne #transationalresearch @cecad.bsky.social

🔬🩺 From bench to bedside Professor @olivercornely.bsky.social und Professor @muellerrom.bsky.social explain in the new #Unimagazin how Basic Research leads to medical Progress. Read more ▶️ uni.koeln/2VKJM #uniköln #unicologne #transationalresearch @cecad.bsky.social

#WHA2026 has concluded - but the work is not done. Fungal infections remain a critical, underrecognized part of AMR. We will continue to push for visibility, investment, and action. #AMR #FungalInfections #OneHealth #WorldHealthOrganization

Honored that our paper on respiratory viruses in patients with hematological malignancies ranked among the top 10% most-viewed papers in the American Journal of Hematology in 2024. Read the publication here: onlinelibrary.wiley.com/doi/full/10....

#KIT2026 wir kommen! 🦠🌍 Ich freue mich auf den Kongress für Infektiologie & Tropenmedizin 2026 in Köln – mit spannenden Themen von KI über Antibiotikaresistenzen bis One Health. 📍 Gürzenich Köln 🔗 kit-kongresse.de #Infektiologie #Tropenmedizin

Looking forward to this important webinar on #Lipoedema, bringing together international experts and patient voices. Delighted that my brother, Prof. Manuel Cornely, will be among the key speakers. Join us on 4 June: www.rsm.ac.uk/events/medic... #MedicineAndMe #Lipedema #Lipoedema

Medicine & Me: Lipoedema in the Spotlight - What Clinicians and Patients Need to Know

This free, RSM webinar, delivered in association with Lipoedema UK, brings together international medical experts and individuals with lived experience to explore the Lipeodema World Alliance Delphi C...

rsm.ac.uk